These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 31140175)

  • 1. Dyslipidemia in Ischemia/Reperfusion Injury.
    Mazo T; D'Annunzio V; Donato M; Perez V; Zaobornyj T; Gelpi RJ
    Adv Exp Med Biol; 2019; 1127():117-130. PubMed ID: 31140175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.
    Ferdinandy P; Schulz R; Baxter GF
    Pharmacol Rev; 2007 Dec; 59(4):418-58. PubMed ID: 18048761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of Cardiovascular Nonmodifiable Risk Factors, Comorbidities and Comedications With Ischemia/Reperfusion Injury and Cardioprotection by Pharmacological Treatments and Ischemic Conditioning.
    Ferdinandy P; Andreadou I; Baxter GF; Bøtker HE; Davidson SM; Dobrev D; Gersh BJ; Heusch G; Lecour S; Ruiz-Meana M; Zuurbier CJ; Hausenloy DJ; Schulz R
    Pharmacol Rev; 2023 Jan; 75(1):159-216. PubMed ID: 36753049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-conditioning and postconditioning to limit ischemia-reperfusion-induced myocardial injury: what could be the next footstep?
    Balakumar P; Rohilla A; Singh M
    Pharmacol Res; 2008 Jun; 57(6):403-12. PubMed ID: 18586514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High cholesterol diet effects on ischemia-reperfusion injury of the heart.
    D'Annunzio V; Donato M; Buchholz B; Pérez V; Miksztowicz V; Berg G; Gelpi RJ
    Can J Physiol Pharmacol; 2012 Sep; 90(9):1185-96. PubMed ID: 22913400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of apoptosis in myocardial reperfusion injury and loss of cardioprotection in diabetes mellitus.
    Badalzadeh R; Mokhtari B; Yavari R
    J Physiol Sci; 2015 May; 65(3):201-15. PubMed ID: 25726180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular basis of cardioprotection: signal transduction in ischemic pre-, post-, and remote conditioning.
    Heusch G
    Circ Res; 2015 Feb; 116(4):674-99. PubMed ID: 25677517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Protective effect of right coronary artery ischemic preconditioning on myocardial ischemia reperfusion injury 
in rabbit heart].
    Li J; Lin G; Huang R; Lu H; Yang Z; Luo W
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Oct; 41(10):1047-1051. PubMed ID: 27807326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ischemia reperfusion injury, ischemic conditioning and diabetes mellitus.
    Lejay A; Fang F; John R; Van JA; Barr M; Thaveau F; Chakfe N; Geny B; Scholey JW
    J Mol Cell Cardiol; 2016 Feb; 91():11-22. PubMed ID: 26718721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous Cardioprotective Agents: Role in Pre and Postconditioning.
    Penna C; Granata R; Tocchetti CG; Gallo MP; Alloatti G; Pagliaro P
    Curr Drug Targets; 2015; 16(8):843-67. PubMed ID: 25751010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time to Give Up on Cardioprotection? A Critical Appraisal of Clinical Studies on Ischemic Pre-, Post-, and Remote Conditioning.
    Heusch G; Rassaf T
    Circ Res; 2016 Aug; 119(5):676-95. PubMed ID: 27539973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impairment of preconditioning-mediated cardioprotection in pathological conditions.
    Balakumar P; Singh H; Singh M; Anand-Srivastava MB
    Pharmacol Res; 2009 Jul; 60(1):18-23. PubMed ID: 19427581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protecting the heart from ischemia/reperfusion injury: an update on remote ischemic preconditioning and postconditioning.
    Donato M; Evelson P; Gelpi RJ
    Curr Opin Cardiol; 2017 Nov; 32(6):784-790. PubMed ID: 28902715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of thioredoxin-1 in ischemic preconditioning, postconditioning and aged ischemic hearts.
    D'Annunzio V; Perez V; Boveris A; Gelpi RJ; Poderoso JJ
    Pharmacol Res; 2016 Jul; 109():24-31. PubMed ID: 26987940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of cardioprotective effect of ischemic pre- and postconditioning in the hyperhomocysteinemic rat heart.
    Balakumar P; Rohilla A; Singh G; Singh K; Singh M
    Methods Find Exp Clin Pharmacol; 2009 Mar; 31(2):71-9. PubMed ID: 19455261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What is Wrong With Cardiac Conditioning? We May be Shooting at Moving Targets.
    Iliodromitis EK; Cohen MV; Dagres N; Andreadou I; Kremastinos DT; Downey JM
    J Cardiovasc Pharmacol Ther; 2015 Jul; 20(4):357-69. PubMed ID: 25627214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical Issues for the Translation of Cardioprotection.
    Heusch G
    Circ Res; 2017 Apr; 120(9):1477-1486. PubMed ID: 28450365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardioprotection: a radical view Free radicals in pre and postconditioning.
    Penna C; Mancardi D; Rastaldo R; Pagliaro P
    Biochim Biophys Acta; 2009 Jul; 1787(7):781-93. PubMed ID: 19248760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocardial postconditioning: next step to cardioprotection.
    Rohilla A; Rohilla S; Kushnoor A
    Arch Pharm Res; 2011 Sep; 34(9):1409-15. PubMed ID: 21975801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Realizing the clinical potential of ischemic preconditioning and postconditioning.
    Yellon DM; Hausenloy DJ
    Nat Clin Pract Cardiovasc Med; 2005 Nov; 2(11):568-75. PubMed ID: 16258568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.